Ralhan Sameer's most recent trade in Veralto Corp was a trade of 24,774 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 24,774 | 24,774 | - | - | Employee Stock Option (Right to Buy) | |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 7,313 | 56,999 | - | 0 | Common Stock | |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 969 | 1,875 | - | - | Veralto Excess Contribution Program - Veralto Stock Fund | |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.78 per share. | 14 Nov 2025 | 3,361 | 49,686 | - | 98.8 | 332,000 | Common Stock |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 18,704 | 18,704 | - | - | Employee Stock Option (Right to Buy) | |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 6,767 | 53,047 | - | 0 | Common Stock | |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 703 | 906 | - | - | Veralto Excess Contribution Program - Veralto Stock Fund | |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.68 per share. | 18 Nov 2024 | 3,833 | 46,280 | - | 102.7 | 393,572 | Common Stock |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 203 | 203 | - | - | Executive Deferred Incentive Program (Veralto Stock Fund) | |
| Veralto | Ralhan Sameer | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2024 | 17,976 | 17,976 | - | - | Employee Stock Option (Right to Buy) | |
| Veralto | Sameer Ralhan | SVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2024 | 7,497 | 50,113 | - | 0 | Common Stock | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 28,807 | 28,807 | - | - | Performance Stock Option (Right to Buy) | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 98,360 | 412,928 (0%) | 0% | 0 | Common Stock | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.35 per share. | 10 Feb 2023 | 42,218 | 370,710 (0%) | 0% | 34.3 | 1,450,188 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 35,188 | 20,175 | - | - | Stock Option (Right to Buy) | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 40.14 per share. | 06 May 2022 | 35,188 | 313,506 (0%) | 0% | 40.1 | 1,412,446 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 06 May 2022 | 35,188 | 348,694 (0%) | 0% | 5.4 | 190,015 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 May 2022 | 20,175 | 0 | - | - | Stock Option (Right to Buy) | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 40.01 per share. | 06 May 2022 | 20,175 | 313,506 (0%) | 0% | 40.0 | 807,202 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.40 per share. | 06 May 2022 | 20,175 | 333,681 (0%) | 0% | 5.4 | 108,945 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 65,722 | 65,722 | - | - | Stock Option (Right to Buy) | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 6,254 | 313,091 (0%) | 0% | 0 | Common Stock | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.98 per share. | 01 Mar 2022 | 550 | 306,837 (0%) | 0% | 26.0 | 14,289 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 11,864 | 311,363 (0%) | 0% | 0 | Common Stock | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.00 per share. | 11 Feb 2022 | 3,975 | 307,388 (0%) | 0% | 30 | 119,250 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 17,482 | 0 | - | - | Stock Option (Right to Buy) | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 29.85 per share. | 02 Dec 2021 | 17,482 | 299,149 (0%) | 0% | 29.9 | 521,838 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 02 Dec 2021 | 17,482 | 316,631 (0%) | 0% | 18.5 | 322,543 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Aug 2021 | 1,890 | 17,482 | - | - | Stock Option (Right to Buy) | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 30 Aug 2021 | 1,890 | 298,792 (0%) | 0% | 35 | 66,150 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 30 Aug 2021 | 1,890 | 300,682 (0%) | 0% | 18.5 | 34,871 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Aug 2021 | 15,085 | 19,372 | - | - | Stock Option (Right to Buy) | |
| Chemours Co | Sameer Ralhan | SVP, CFO | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 27 Aug 2021 | 15,085 | 298,792 (0%) | 0% | 35 | 527,975 | Common Stock |
| Chemours Co | Sameer Ralhan | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.45 per share. | 27 Aug 2021 | 15,085 | 313,877 (0%) | 0% | 18.4 | 278,318 | Common Stock |